The
InhaleSur device described herein offers a unique opportunity to improve
compliance in a market that is untapped; proactive inhaler protocol training
occurs in physicians offices and pharmacies, but a thorough literature search
uncovered no core technology that continually monitors inhaler usage throughout
the entire course of treatment. InhaleSur will improve compliance with inhaler
protocols first by ensuring that each canister is sufficiently shaken before
inhalation of the medications within. Proof-of-concept for this device has been
successfully demonstrated with a simple Arduino microcontroller that uses an
accelerometer and a push button to detect the magnitude and frequency of device
shaking; it also records when the canister has been compressed to alert the
user when a refill is required. The accelerometer used for this proof-of-concept
device can only measure tilt relative to gravitational forces rather than
actual linear acceleration when transmitting data in real-time, and this is
currently a device design weakness. Future work will incorporate a more
sophisticated accelerometer into the design. Miniaturization of the device is
also critical to ensure portability. The core strengths of InhaleSur are that
it provides real-time feedback for the entire course of treatment for a patient
suffering from asthma and removes the ambiguity associated with guessing
whether or not the medication is sufficiently mixed. Additionally, knowing when
to replace the medication canister reduces wasted drugs and ensures that
patients are getting as effective a treatment as possible. Future design
iterations will include the ability monitor the user’s force of inhalation as well
as the ability to alert the user to the proper compression time of the canister.
Commercialization designs of InhaleSur will also incorporate auditory alerts to
these factors to make the
device accessible to blind persons.
InhaleSur will improve compliance with inhaler procedures and has the
potential to dramatically impact the quality of life for asthma sufferers.
No comments:
Post a Comment